Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
Airflow limitation is common exist in idiopathic bronchiectasis patients. However, there are
few evidence on the treatment of bronchodilator in bronchiectasis with airflow limitation.
The efficacy and safety of dual bronchodilator in idiopathic bronchiectasis with airflow
limitation are still unclear. Thus, the investigators conduct a multicenter, open-label
randomized controlled trial to investigate the efficacy and safety of dual bronchodilator in
idiopathic bronchiectasis with airflow limitation.